NeuroRX to Present Phase 2 Efficacy Data for NRX-101 at 2019 BIO International Convention Yahoo FinanceFirst drug targeting suicidal bipolar depression, awarded FDA Breakthrough Therapy Designation PHILADELPHIA , June 3, 2019 /PRNewswire/ -- NeuroRX, ...